2016
DOI: 10.1080/14779072.2016.1217154
|View full text |Cite
|
Sign up to set email alerts
|

Previous challenges and current progress–the use of total artificial hearts in patients with end-stage heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
11
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 14 publications
0
11
0
Order By: Relevance
“…However, despite the research efforts detailed above, the SynCardia TAH, which is the evolution of the Jarvik 7 then renamed CardioWest, still is the only device currently FDA‐approved for total cardiac replacement . This device has been implanted in almost 2,000 patients, in part due to a current smaller (50‐cc) system for adolescents and children, despite its difficult long‐term durability due to the finite cyclic endurance of the flexible membranes .…”
Section: Biosketchmentioning
confidence: 99%
See 4 more Smart Citations
“…However, despite the research efforts detailed above, the SynCardia TAH, which is the evolution of the Jarvik 7 then renamed CardioWest, still is the only device currently FDA‐approved for total cardiac replacement . This device has been implanted in almost 2,000 patients, in part due to a current smaller (50‐cc) system for adolescents and children, despite its difficult long‐term durability due to the finite cyclic endurance of the flexible membranes .…”
Section: Biosketchmentioning
confidence: 99%
“…Recently, Dr. Alain Carpentier, in collaboration with European Aerospace and Defense Systems, introduced the pulsatile Carmat TAH which uses bovine pericardium for its blood‐contacting surfaces making it almost “biological” which should be a further the ideal concept in mechanical circulatory support .…”
Section: Biosketchmentioning
confidence: 99%
See 3 more Smart Citations